George Medicines: New England Journal of Medicine publishes global stroke outcomes trial that demonstrated reduction of ...
Significant lowering of systolic blood pressure of 9mmHg on top of background treatment maintained with GMRx2 over an average follow-up of 3 years Safety findings similar to previous studies of GMRx2 London, UK, Boston, MA, 22 April 2026 – George Medicines …